Healthcare

Categories

Pharmaceutical and Healthcare
PUBLISHED
July 2025
STARTING FROM
$3250

Digestive Drugs Market Size, Trends, and Forecast Analysis (2024-2032)

Digestive Drugs Market by Type (Branded, Generic), Drug Class (5-aminosalicylates, GI stimulants, Laxatives, Antacids, H2 Antagonists, Antidiarrheals, Others), Application (Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome, Ulcerative Colitis, Others) and Region...

Pharmaceutical and Healthcare
PUBLISHED
July 2025
STARTING FROM
$3250

Idiopathic Hypersomnia Treatment Market Insights, Size, Share & Growth Forecast to 2032

Idiopathic Hypersomnia Treatment Market by Type (Stimulant Medications, Non-Stimulant Wake-Promoting Medications, Sodium Oxybate), Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region...

Pharmaceutical and Healthcare
PUBLISHED
July 2025
STARTING FROM
$3250

Idiopathic Pulmonary Fibrosis Market Growth Analysis & Forecast (2024-2032)

Idiopathic Pulmonary Fibrosis Market by Drug (Pirfenidone, Nintedanib, Others), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital, Pharmacies, Retail Pharmacies, Online Pharmacies), and Region...

Pharmaceutical and Healthcare
PUBLISHED
July 2025
STARTING FROM
$3250

Parkinsons Disease Therapeutics Market - Comprehensive Analysis & Growth Outlook to 2032

Parkinsons Disease Therapeutics Market By Drug Class (Levodopa, Dopamine agonists, MAO-B inhibitors, Anticholinergics, Others (Catechol-O-methyl transferase [COMT] inhibitors and amantadine, among Others)), Route of Administration (Oral, Injectable, Nasal, Transdermal, Others (Rectal, Sublingual, am...

Pharmaceutical and Healthcare
PUBLISHED
July 2025
STARTING FROM
$3250

Pain Management Drugs Market - Trends, Opportunities, and Growth Forecast (2024-2032)

Pain Management Drugs Market By Drug class (NSAIDS, Anaesthetics, Anticonvulsants, Antimigraine drugs, Antidepressant drugs, Opioids, Non-narcotic analgesics and Other drugs), Indication Type (Arthritic pain, Neuropathic pain, Cancer pain, Chronic back pain, post-operative pain, Migraine, Fibromyalg...

Pharmaceutical and Healthcare
PUBLISHED
July 2025
STARTING FROM
$3250

Olanzapine Market - Insights, Size, Share & Growth Forecast to 2032

Olanzapine Market by Route of Administration (Oral, Parenteral), Distribution channel (Hospital Pharmacies, Drug stores and Retail Pharmacies, Online Providers), Application (Bipolar Disorder, Others, Schizophrenia), and Region (North America, Eastern Europe, Western Europe, Asia Pacific, Middle Eas...

Pharmaceutical and Healthcare
PUBLISHED
July 2025
STARTING FROM
$3250

Nootropics Brain Supplements Market - Growth Analysis & Forecast (2024-2032)

Nootropics Brain Supplements Market by Product Type (Natural Nootropics, Synthetic Nootropics), Application (Memory Enhancement, Focus & Attention, Mood & Depression Management, Sleep Improvement), Distribution Channel (Online, Offline (Retail Stores, Pharmacies)), and Region...

Pharmaceutical and Healthcare
PUBLISHED
July 2025
STARTING FROM
$3250

Glucosamine Market Future Outlook, Trends & Forecast Analysis (2024-2032)

Glucosamine Market by Product (Glucosamine Sulphate, Glucosamine Hydrochloride, N-acetylglucosamine, Others), Application (Supplement Food and Beverage, Others), and Region...

Pharmaceutical and Healthcare
PUBLISHED
July 2025
STARTING FROM
$3250

Pediatric Nutrition Market: Comprehensive Analysis & Market Outlook (2024-2032)

Pediatric Nutrition Market By Product Type (Infant Nutrition, Toddler Nutrition, Children’s Nutrition), Form (Powder, Liquid, Ready-to-Use), Distribution Channel (Supermarkets/Hypermarkets, Pharmacies, Online Retailers, Others), End-User (Hospitals, Clinics, Homecare), Age Group (0-6 Months, 6-12 ...

Pharmaceutical and Healthcare
PUBLISHED
July 2025
STARTING FROM
$3250

Glaucoma Eye Drops Market - Trends, Opportunities, and Growth Forecast (2024-2032)

Glaucoma Eye Drops Market by Drug Type (Prostaglandin analogs Beta blockers Alpha agonists Carbonic Anhydrase Inhibitors (CAIs) Combined Medications Others (rho-kinase inhibitor, Cholinergic agonists)), Disease Indication (Angle-closure Glaucoma Open-angle Glaucoma), Distribution Channel (Hospital P...